Investing

AstraZeneca : AZN

AZN

Stock Data

$89.83

$0.46 (0.51%)

Asset Type

Common Stock

Exchange

NASDAQ

Currency

USD

Country

USA

Sector

HEALTHCARE

Industry

DRUG MANUFACTURERS - GENERAL

AstraZeneca is a global biopharmaceutical giant, dedicated to the discovery, development, and commercialization of prescription medicines. Its portfolio spans a wide range of areas including cardiovascular, renal, metabolism, oncology, and treatments for rare diseases and COVID-19. The company is known for leading products like Tagrisso, Imfinzi, and Lynparza, among others. AstraZeneca not only serves healthcare professionals and patients worldwide but also engages in significant collaborations, such as with Neurimmune AG, to push the boundaries of medicine. Headquartered in Cambridge, UK, AstraZeneca continues to be at the forefront of addressing global health challenges.

All AstraZeneca Articles

211 Articles

Rich Duprey | Oct 25, 2025 at 10:32 AM EDT

Nancy Pelosi Is Crushing The S&P 500 And These Are Her 3 Best Positions

Warren Buffett may be considered the greatest investor of our time, but even he can’t touch the prowess of California…

Rich Duprey | Oct 21, 2025 at 9:39 AM EDT

Did IonQ Just Unlock Quantum Computing’s True Potential — And a Massive Stock Rally?

Quantum computing has emerged as a prime target for investors chasing high-growth tech sectors. Over the past year, some stocks…

Rich Duprey | Oct 5, 2025 at 7:17 AM EDT

Quantum Stocks Are Surging: Time to Load Up on D-Wave, or Is IonQ the Safer Bet?

Quantum computing holds immense promise to transform industries by tackling problems beyond the reach of traditional computers. It could accelerate…

Rich Duprey | Sep 15, 2025 at 10:40 AM EDT

Is IonQ the Next Nvidia After Surging Past $55?

From Steady Climb to Breakout Momentum On Friday, IonQ‘s (NYSE:IONQ) stock exploded nearly 19%, closing above $55 per share for…

Rich Duprey | Aug 5, 2025 at 11:24 AM EDT

Is IonQ the Key to Unlocking AI’s Quantum Potential?

Quantum Computing’s Potential to Reshape AI Quantum computing, still in its infancy, promises to revolutionize computational power by leveraging quantum…

Rich Duprey | Jul 3, 2025 at 11:58 AM EDT

Quantum Computing Stocks: Billion-Dollar Groundbreaking Opportunity or Money Sinkhole?

Should You Invest in Quantum Computing Stocks? Quantum computing promises to revolutionize industries by solving complex problems beyond the reach…

Rich Duprey | May 13, 2025 at 12:21 PM EDT

Big Earnings Beats: 6 Stocks That Spiked After Reporting Results

We’re winding down earnings season, and the old Wall Street adage that “earnings drive stock prices” continues to prove true.…

Gerelyn Terzo | Apr 3, 2025 at 10:24 AM EDT

Live Nasdaq Composite: FIVE Falls, AZN and PEP Rise From Tariff Ashes

The markets have succumbed to the tariff-fueled selling pressure, and there is nowhere to hide. President Trump’s tariff plan is…

Trey Thoelcke | Feb 14, 2025 at 8:45 AM EST

AbbVie Just Paid Investors: Here’s How Much They Received

AbbVie just rewarded its shareholders again with a dividend. This stock has boosted its payout annually for more than 50…

Lee Jackson | Dec 30, 2024 at 11:14 AM EST

US Large Cap Dividend Stocks Should Roll in 2025: Our 4 Favorite Picks

These four large-cap dividend stocks offer value, upside potential, and strong dividend coverage. They are top picks for the coming…

Chris MacDonald | Dec 3, 2024 at 12:35 PM EST

3 Best Growth Stocks To Buy Now

Finding the “best” growth stocks to buy really is a subjective task, isn’t it? What’s considered to be the best…

Lee Jackson | Oct 13, 2024 at 2:40 PM EDT

5 Blue Chip Dividend Stocks to Own If You Had to Hold Them Forever

These five blue chip dividend stocks would be ideal for investors who had to hold them forever, as they provide…

Chris MacDonald | Oct 7, 2024 at 12:44 PM EDT

Like Him Or Hate Him, George Soros Is Betting Big On These 3 Stocks You Should Be Watching

George Soros is among the most renowned and controversial hedge fund managers on the planet. Well known for his political…

Rich Duprey | Sep 20, 2024 at 8:20 AM EDT

George Soros $4 Billion Hedge Fund Can’t Stop Buying These 3 Stocks

Billionaire investor George Soros became nearly a household name in the early 1990’s by shorting the British pound and making…

Trey Thoelcke | Sep 19, 2024 at 9:15 AM EDT

Prediction: This Will Be the Biggest Pharma Stock in 10 Years 

Eli Lilly is the clear frontrunner to be the largest pharmaceutical stock in 2034. See what the company's prospects are…